Literature DB >> 23794716

The IκB family member Bcl-3 stabilizes c-Myc in colorectal cancer.

Zhanjie Liu, Yuhang Jiang, Yinyong Hou, Yiming Hu, Xinwei Cao, Yu Tao, Chen Xu, Sanhong Liu, Shouli Wang, Lunshan Wang, Yufang Shi, Ulrich Siebenlist, Xiaoren Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23794716     DOI： 10.1093/jmcb/mjt020

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN： 1759-4685            Impact factor:   6.216


× No keyword cloud information.
  18 in total

1.  Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.

Authors:  Jingjing Tian; Xibao Hu; Wei Gao; Jie Zhang; Ming Chen; Xinrong Zhang; Junhong Ma; Hongxia Yuan
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Zinc finger protein X-linked is overexpressed in colorectal cancer and is associated with poor prognosis.

Authors:  Jin Jiang; Lu-Ying Liu
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

3.  Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.

Authors:  Yu Tao; Zhanjie Liu; Yingyong Hou; Shouli Wang; Sanhong Liu; Yuhang Jiang; Dan Tan; Qiulin Ge; Cuifeng Li; Yiming Hu; Zhi Liu; Xi Chen; Qi Wang; Mingliang Wang; Xiaoren Zhang
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

Review 4.  Significant position of C-myc in colorectal cancer: a promising therapeutic target.

Authors:  Li Tan; Dong Peng; Yong Cheng
Journal:  Clin Transl Oncol       Date:  2022-08-16       Impact factor: 3.340

5.  Sterol regulatory element-binding protein 1 cooperates with c-Myc to promote epithelial-mesenchymal transition in colorectal cancer.

Authors:  Duanyang Zhai; Chunhui Cui; Lang Xie; Lianxu Cai; Jinlong Yu
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

6.  The tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma.

Authors:  Zheng Liu; Guangwu Zhang; Jian Li; Jiabang Liu; Pengfeng Lv
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

7.  BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer.

Authors:  Hu Zhao; Wuliang Wang; Qinghe Zhao; Guiming Hu; Kehong Deng; Yuling Liu
Journal:  Onco Targets Ther       Date:  2016-10-26       Impact factor: 4.147

8.  BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.

Authors:  Bettina C Urban; Tracey J Collard; Catherine J Eagle; Samantha L Southern; Alexander Greenhough; Maryam Hamdollah-Zadeh; Anil Ghosh; Richard Poulsom; Christos Paraskeva; Andrew Silver; Ann C Williams
Journal:  Gut       Date:  2015-06-01       Impact factor: 23.059

9.  The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells.

Authors:  W Tang; H Wang; H L Ha; I Tassi; R Bhardwaj; E Claudio; U Siebenlist
Journal:  Oncogene       Date:  2016-05-02       Impact factor: 9.867

10.  Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.

Authors:  Sandeep C Chaudhary; Xiuwei Tang; Aadithya Arumugam; Changzhao Li; Ritesh K Srivastava; Zhiping Weng; Jianmin Xu; Xiao Zhang; Arianna L Kim; Kristopher McKay; Craig A Elmets; Levy Kopelovich; David R Bickers; Mohammad Athar
Journal:  Oncotarget       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.